Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Press ReleaseJun | 25 | 2020
Legislation under consideration in U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at MGH and colleagues from several other institutions demonstrates that its impact will depend on key details in the bill’s final language.
ICU patients on ventilators who had abnormally high factor V activity were at higher risk for blood clots, and when factor V was lower, the risk for death was increased.
Los pacientes hospitalizados con infecciones graves por el COVID-19 que tienen altos niveles del factor V (proteína de coagulación sanguínea) corren un riesgo elevado de sufrir lesiones graves por coágulos sanguíneos como la trombosis venosa profunda o la embolia pulmonar.
The new base editing platform may help researchers understand and correct genetic diseases by selective editing of single DNA 'letters' across nucleobase classes.
A study by investigators from the Massachusetts General Hospital Cancer Center has found that, contrary to common assumptions, the fact that a specific genetic mutation is frequently found in particular tumors may not signify that mutation drives cancer development and progression.
A new animal model developed by Massachusetts General Hospital investigators promises to be less expensive, easier to use and to improve personalized therapies for cancers and potentially other diseases.
